To determine whether CCT could inhibit inflammation in an HFD-induced NAFLD-mouse model, the levels of TNF-α, IL-1β, and IL-6 were measured in the liver tissue. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.